Thu, Aug 24, 2017 | updated 02:16 PM IST

6-months clinical trial data finds Indian thin strut fully dissolvable stent to be safe

Updated: Nov 02, 2016 10:34 IST      
6-months clinical trial data finds Indian thin strut fully dissolvable stent to be safe

New Delhi [India], Nov2 (ANI): Findings of the six month clinical trial on the first thin strut fully dissolvable stent in the world, developed in India, were unveiled at the prestigious main arena, Late Breaking Clinical Trials/First Report Investigations at the Cardiovascular Therapeutics (TCT) 2016, Washington DC on October 31.

The TCT is the biggest and best regarded meeting of interventional cardiologists in the world. This was a proud moment for India, as the data was presented by the eminent interventional cardiologist Dr Ashok Seth, Chairman Fortis Escorts Heart Institute, who was the principal investigator of the study.

The study titled MeRes-1 is the first-in-man study of the novel thin-strut PLLA-based sirolimus-eluting bioresorbable vascular stent (MeRes100). It considered Six-Month Clinical, Angiographic, Intravascular ultrasound (IVUS), and Optical coherence tomography (OCT) results in patients with Coronary Artery Disease.

Presenting the findings of the study, Dr. Seth said, "This is a big day for India and the 'Make in India' program. It also reveals to the world that our Indian device industry has the ability to be innovative, creative and support high quality research. The innovative design of the MeRes100 scaffold developed in India addresses some of the limitations of currently available Bio Resorbable Stents (dissolvable stents) and may have higher success and lower complication rates in the long term. It would also cost much lesser than the currently available dissolvable stents and therefore give more benefit to higher number of patients. The MeRes-1, first-in-man study demonstrates that this new generation thinner strut sirolimus eluting BRS is both safe and effective at six months. These encouraging results provide the basis for further studies using wider range of length and sizes in more complex and larger patient population."

The MeRes100 is a low profile 100µm thin strut PLLA based BRS with a unique hybrid design featuring open cells at the center and closed cells at the edges resulting in improved track-ability and access to side branches. It also has enhanced visibility with three circumferential radio opaque markers at each end.

In this prospective, multicenter, single arm trial of MeRes100 BRS, a total of 108 patients (116 lesions) were enrolled at 16 Indian sites from May 2015 to April 2016.

The primary end-point was Major Adverse Cardiac Events (MACE), a composite of cardiac death, myocardial infarction, Ischaemia Driven Target Lesion Revascularization (ID-TLR), and Ischaemia Driven Target Vessel Revascularization (ID-TVR) at six months. The secondary end-point was scaffold thrombosis at six months.

The study found no MACE or stent thrombosis (ST) after the deployment of the scaffold up to six month follow-up.

Quantitative Coronary Analysis (QCA) data at six months demonstrated very favourable in scaffold late lumen loss of 0.15±0.26mm. Intravascular ultrasound (IVUS) and Optical coherence tomography (OCT) analysis showed no scaffold recoil and near complete strut coverage (99.3percent) with neointima.

The TCT is the annual scientific symposium of the Cardiovascular Research Foundation (CRF) featuring a number of first report investigations on novel stents that could become the next generation of bioresorbable stents in patients.

"Bioresorbable stents (dissolvable stents) have the potential to be greatly impactful in the treatment of coronary artery disease, and it is exciting to see these first report investigations of several new and novel stents advancing the technology forward," said Ajay Kirtane, , a Co-Director of TCT.

"These results give us the first insights into their safety and efficacy, but larger randomized trials are necessary in order to establish their role in clinical practice," he added. (ANI)

Can nicotine reduction help in curbing addiction?

Updated: Aug 24, 2017 08:49 IST     

Washington D.C. [USA], August 24 (ANI): According to a new research, a study examining the effects of nicotine reduction among more vulnerable smokers supports the FDA's recent recommendation for lowering nicotine to non-addictive levels.

Full Story >>

Washington D.C. [USA], August 24 (ANI): If you are one of those suffering from Liver Cancer, we have some important news for you.

Full Story >>

Washington D.C. [USA], August 24 (ANI): In a new research, a group of scientists highlighted the importance of immune cell metabolism for maintaining a balanced immune response.

Full Story >>

Fill the gap to keep your teeth healthy for life

Updated: Aug 23, 2017 11:29 IST     

New Delhi [India], August 23 (ANI): Dental implants are evolving as a popular and preferred choice of tooth replacement today, from just being a procedure that was exciting but hardly predictable, for patients looking to replace their missing teeth.

Full Story >>

Check out for genetic testing in cardiovascular diseases

Updated: Aug 23, 2017 11:17 IST     

New Delhi [India], August 23 (ANI): The last decade has seen an explosion in cardiovascular diseases, with 60 percent of premature death attributable to cardiac causes. With high case fatality rate after cardiac events, fewer experts of advanced cardiac interventions and high cost of such interventions; disease prevention assumes a very promising and attractive solution.

Full Story >>

Washington D.C. [USA], August 23 (ANI): According to a new research, Oral steroids should not be used for treating acute lower respiratory tract infection or chest pains in adults who don't have asthma or other chronic lung disease, as they do not reduce the duration or severity of symptoms.

Full Story >>

New Delhi [India], Aug 23, (ANI): The Indian Council of Medical Research (ICMR) along with the Department of Health and Family Welfare of the Ministry of Health and Family Welfare, Government of India signed a MoU with the International Vaccine Institute (IVI), South Korea to collaborate on vaccine research and development in the recently held tripartite meeting. The Memorandum of Understanding will strengthen the relationship between IVI and India.

Full Story >>

Night-time symptoms- The lesser known side of COPD

Updated: Aug 22, 2017 15:47 IST     

New Delhi [India], August 22 (ANI): Chronic Obstructive Pulmonary Disease (COPD), a condition that damages the lung airways causing a range of symptoms like chest tightness, breathlessness, wheezing and persistent cough, is one of the leading causes of morbidity and mortality in the country.

Full Story >>

Mumbai (Maharashtra) [India], August 22 (ANI): Not many are aware of the fact that India is on the edge of becoming the 'Diabetes Capital of the World' overtaking China, which earlier had the largest number of diabetics.

Full Story >>

Using quality stents is of utmost importance: Experts

Updated: Aug 22, 2017 10:35 IST     

New Delhi [India], August 22 (ANI): Stents are a powerful tool in the fight against heart disease and specialists have emphasised on the need of using quality stents for best patient outcomes.

Full Story >>

Washington D.C. [USA], August 22 (ANI): There may be no magical solution treating liver cancer or fatty liver disease, but knowing the right targets will help science develop the most effective treatments.

Full Story >>

Washington D.C. [USA], August 22 (ANI): According to a recent research, a group of researchers have found and validated a practical tool for identifying diabetes patients who are at the highest risk for being admitted to an emergency department or hospital due to severe hypoglycemia, or very low blood sugar.

Full Story >>

Study reveals potential target for alcohol liver disease

Updated: Aug 22, 2017 08:02 IST     

Washington D.C. [USA], August 22 (ANI): In a recent research, the scientists have found a new protective response in the organ that might be targeted to help treat alcoholic liver disease.

Full Story >>

Mussel-inspired glue promises safer fetal surgery

Updated: Aug 21, 2017 09:04 IST     

Washington D.C. [USA], Aug 21 (ANI): Whether to perform surgery on a fetus is a heart-wrenching decision, but now, a team of researchers has come up with glue that could one day make the procedures safer.

Full Story >>

Turns out, sugars in breastmilk keep bacteria at bay

Updated: Aug 21, 2017 07:59 IST     

Washington D.C. [USA], Aug 21 (ANI): Mother's milk, which consists of a complex and continually changing blend of proteins, fats and sugars, helps protect babies against bacterial infections.

Full Story >>

Washington D.C. [USA], Aug 20 (ANI): Good news! Now an eye test can predict Alzheimer's disease two decades prior to symptoms emergence, claims a new study.

Full Story >>

Dengue: what you should know

Updated: Aug 20, 2017 07:01 IST     

New Delhi [India], August 20 (ANI): Dengue, a viral disease transmitted by mosquitoes, causes about 50 to 100 million infections per year worldwide. According to the statistics by the National Vector Borne Disease Control Programme, India has recorded over 33, 964 cases of dengue in 2017 so far.

Full Story >>

Quashing the claim against antidepressants

Updated: Aug 19, 2017 09:39 IST     

Washington D.C. [USA], Aug 19 (ANI): A recent study has rebutted the claim that antidepressants do not work.

Full Story >>

Washington D.C. [USA], Aug 19 (ANI): Turns out, smokers are 20 percent more likely to quit if cigarettes cost a dollar more.

Full Story >>

New HIV-tracking approach paves way for better therapies

Updated: Aug 19, 2017 08:25 IST     

Washington D.C. [USA], Aug 19 (ANI): A team of researchers has come up with a novel method of tracking HIV infection that could help lead to the development of novel therapies.

Full Story >>